Print Page     Close Window     

SEC Filings

8-K
SERES THERAPEUTICS, INC. filed this Form 8-K on 10/16/2017
Entire Document
 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    SERES THERAPEUTICS, INC.
  Date: October 16, 2017     By:   /s/ Thomas J. DesRosier
        Name: Thomas J. DesRosier
       

Title: Executive Vice President and Chief Legal

Officer


© Seres Therapeutics. All Rights Reserved.